These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38466297)

  • 1. Episode-Based Cost Sharing to Prospectively Guarantee Patients' Out-of-Pocket Costs.
    Horný M; Anderson DM; Fendrick AM
    JAMA Intern Med; 2024 Jun; 184(6):597-598. PubMed ID: 38466297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Will the Affordable Care Act's Cost-Sharing Reductions Affect Consumers' Out-of-Pocket Costs in 2016?
    Collins SR; Gunja M; Beutel S
    Issue Brief (Commonw Fund); 2016 Mar; 6():1-17. PubMed ID: 27017638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ACA's Zero Cost-Sharing Mandate and Trends in Out-of-Pocket Expenditures on Well-Child and Screening Mammography Visits.
    Kirby JB; Davidoff AJ; Basu J
    Med Care; 2016 Dec; 54(12):1056-1062. PubMed ID: 27479595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of cost sharing on women's use of annual examinations and effective contraception.
    Dalton VK; Carlos RC; Kolenic GE; Moniz MH; Tilea A; Kobernik EK; Fendrick AM
    Am J Obstet Gynecol; 2018 Jul; 219(1):93.e1-93.e13. PubMed ID: 29752935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Legal and Practical Implications of Copay Accumulator and Maximizer Programs.
    Linehan JS
    Manag Care; 2019 Feb; 28(2):42-44. PubMed ID: 30883325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiered cost sharing and health care demand.
    Ackley CA
    J Health Econ; 2022 Sep; 85():102663. PubMed ID: 35944308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
    Harrison RF; Fu S; Sun CC; Zhao H; Lu KH; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2021 Jul; 225(1):68.e1-68.e11. PubMed ID: 33549538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Workers absorbing costs. Employers say benefit changes on way as healthcare expenditures continue to soar.
    Vesely R
    Mod Healthc; 2010 Nov; 40(46):24-7. PubMed ID: 21192360
    [No Abstract]   [Full Text] [Related]  

  • 9. The Economic Burden of Out-of-Pocket Expenses for Plastic Surgery Procedures.
    Billig JI; Chen JS; Lu YT; Chung KC; Sears ED
    Plast Reconstr Surg; 2020 Jun; 145(6):1541-1551. PubMed ID: 32459783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare Advantage Members' Expected Out-Of-Pocket Spending For Inpatient And Skilled Nursing Facility Services.
    Keohane LM; Grebla RC; Mor V; Trivedi AN
    Health Aff (Millwood); 2015 Jun; 34(6):1019-27. PubMed ID: 26056208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling.
    Sloan CE; Millo L; Gutterman S; Ubel PA
    JAMA Netw Open; 2021 Nov; 4(11):e2133188. PubMed ID: 34739059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reforming beneficiary cost sharing to improve Medicare performance.
    Zuckerman S; Shang B; Waidmann T
    Inquiry; 2010; 47(3):215-25. PubMed ID: 21155416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
    Starner CI; Alexander GC; Bowen K; Qiu Y; Wickersham PJ; Gleason PP
    Health Aff (Millwood); 2014 Oct; 33(10):1761-9. PubMed ID: 25288420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage.
    Chua KP; Conti RM
    Am J Prev Med; 2021 Apr; 60(4):537-541. PubMed ID: 33612337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Growing Problem of Out-of-Pocket Costs and Affordability in Employer-Sponsored Insurance.
    Rosenthal MB
    JAMA; 2021 Jul; 326(4):305-306. PubMed ID: 34241620
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products.
    Gupta A; Antonarakis ES; Blaes AH; Booth CM; Dusetzina SB
    JAMA Netw Open; 2022 Sep; 5(9):e2231475. PubMed ID: 36178694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US.
    Shafer PR; Horný M; Dusetzina SB
    JAMA Netw Open; 2022 Sep; 5(9):e2233006. PubMed ID: 36107430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSR Cuts Bring Unintended Consequences, Prompt State Responses.
    Kirkner RM
    Manag Care; 2017 Dec; 26(12):12-13. PubMed ID: 29272230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020.
    Chua KP; Conti RM; Becker NV
    JAMA Netw Open; 2021 Oct; 4(10):e2129894. PubMed ID: 34661662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D.
    DeJong C; Masuda C; Chen R; Kazi DS; Dudley RA; Tseng CW
    JAMA Intern Med; 2020 Dec; 180(12):1696-1699. PubMed ID: 32926091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.